Skip to main content

Table 1 Participants’ characteristics at baseline and cognitive status at three months

From: Diagnostic accuracy of the Clock Drawing Test in screening for early post-stroke neurocognitive disorder: the Nor-COAST study

Demographics

n = 554

 

 Age in years, mean (SD)

 

71.5 (11.8)

 Female sex, n (%)

 

238 (43.0)

 Education in years, mean (SD)

 

12.5 (3.8)

Stroke subtype, n (%)

 Infarction

 

504 (91.0)

 Haemorrhage

 

50 (9.0)

TOAST classification, n (%)

n = 488/504

 

 Large-vessel disease

 

49 (8.8)

 Cardioembolic disease

 

112 (20.2)

 Small-vessel disease

 

113 (20.4)

 Other aetiology

 

13 (2.3)

 Undetermined aetiology

 

201 (36.3)

Treatment, n (%)

 Thrombolysis

 

129 (23.3)

 Thrombectomy

 

11 (2.0)

Function, mean (SD)

 NIHSS score, day 1 (0–42)

n = 542

2.6 (3.7)

 Pre-stroke mRS score (0–6)

n = 552

0.8 (1.0)

 mRS score at discharge (0–6)

n = 552

2.0 (1.3)

 Barthel Index (0–100)

n = 553

89.2 (18.0)

 Pre-stroke GDS score (0–7), mean (SD)

 3, mild NCD, n (%)

 4–7, major NCD, n (%)

n = 549

1.4 (0.8)

33 (6.0)

19 (3.5)

Cognitive status at three months, n (%)

 Normal cognition

 

253 (45.7)

 Mild NCD

 

161 (29.1)

 Major NCD

 

140 (25.3)

CDT score, n (%)

 0–3

 

139 (25.1)

 4

 

165 (29.8)

 5

 

250 (45.1)

  1. TOAST Trial of ORG 10172 in Acute Stroke Treatment, NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, GDS Global Deterioration Scale, NCD neurocognitive disorder, CDT Clock Drawing Test, SD standard deviation